Evidence map›Paper›PMID 19451239›Full record

ArticleInfection and immunity2009

Characterization of a novel ADAM protease expressed by Pneumocystis carinii.

Cassie C Kennedy, Theodore J Kottom, Andrew H Limper

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Cassie C KennedyDepartment of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Theodore J Kottom
Andrew H Limper
Mayo Clinic · US

Funding

Pneumocystis: Macrophage & Epithelial ActivationR01HL062150 · NHLBI · MAYO CLINIC ROCHESTER · PI ANDREW H LIMPER · 1998 to 2026
$9.2M
Control of the Pneumocystis carinii Life CycleR01HL055934 · NHLBI · MAYO CLINIC ROCHESTER · PI LIMPER, ANDREW H · 1995 to 2008
$3.0M
NHLBI RESPIRATORY BIOLOGY RESEARCH TRAINING GRANTT32HL007897 · NHLBI · MAYO CLINIC ROCHESTER · PI LIMPER, ANDREW H · 1998 to 2007
$1.7M
NHLBI NIH HHS R01 HL055934NHLBI NIH HHS R01 HL062150NHLBI NIH HHS R01-HL55934NHLBI NIH HHS R01-HL62150NHLBI NIH HHS T32 HL007897NHLBI NIH HHS T32-HL07897
6 · The paper itself

Abstract

Pneumocystis species are opportunistic fungal pathogens that cause severe pneumonia in immunocompromised hosts. Recent evidence has suggested that unidentified proteases are involved in Pneumocystis life cycle regulation. Proteolytically active ADAM (named for "a disintegrin and metalloprotease") family molecules have been identified in some fungal organisms, such as Aspergillus fumigatus and Schizosaccharomyces pombe, and some have been shown to participate in life cycle regulation. Accordingly, we sought to characterize ADAM-like molecules in the fungal opportunistic pathogen, Pneumocystis carinii (PcADAM). After an in silico search of the P. carinii genomic sequencing project identified a 329-bp partial sequence with homology to known ADAM proteins, the full-length PcADAM sequence was obtained by PCR extension cloning, yielding a final coding sequence of 1,650 bp. Sequence analysis detected the presence of a typical ADAM catalytic active site (HEXXHXXGXXHD). Expression of PcADAM over the Pneumocystis life cycle was analyzed by Northern blot. Southern and contour-clamped homogenous electronic field blot analysis demonstrated its presence in the P. carinii genome. Expression of PcADAM was observed to be increased in Pneumocystis cysts compared to trophic forms. The full-length gene was subsequently cloned and heterologously expressed in Saccharomyces cerevisiae. Purified PcADAMp protein was proteolytically active in casein zymography, requiring divalent zinc. Furthermore, native PcADAMp extracted directly from freshly isolated Pneumocystis organisms also exhibited protease activity. This is the first report of protease activity attributable to a specific, characterized protein in the clinically important opportunistic fungal pathogen Pneumocystis.

Indexed as

ADAM ProteinsAmino Acid SequenceBase SequenceBlotting, NorthernCatalytic DomainCloning, MolecularCoenzymesDNA, FungalFungal ProteinsGene ExpressionGene Expression ProfilingMolecular Sequence DataPeptide HydrolasesPneumocystis cariniiRecombinant ProteinsSaccharomyces cerevisiaeADAM ProteinsCoenzymesDNA, FungalFungal ProteinsPeptide HydrolasesRecombinant ProteinsZinc

Identifiers

PMID19451239
PMCPMC2715687
OpenAlexW2164571560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.